Human blood vessels release tumor necrosis factor-alpha from a smooth muscle cell source

W H Newman1, L M Zhang, S K Leeper-Woodford

  • 1Division of Basic Medical Science, Mercer University School of Medicine, Macon, GA., USA.

Critical Care Medicine
|February 1, 1996
PubMed
Abstract

Insights

Human blood vessels, including arteries and veins, can produce tumor necrosis factor alpha (TNF) when exposed to bacterial lipopolysaccharide (endotoxin). This suggests a potential role for vascular tissue in the inflammatory response during sepsis.

Area of Science:

  • Immunology
  • Vascular Biology
  • Sepsis Research

Background:

  • Septic shock is characterized by elevated plasma tumor necrosis factor alpha (TNF).
  • Macrophages are considered the primary source of TNF in sepsis, stimulated by bacterial lipopolysaccharide (endotoxin).
  • The potential contribution of vascular tissue to TNF production in sepsis remains less understood.

Purpose of the Study:

  • To investigate whether human vascular tissue, specifically arteries and veins, can produce TNF in response to bacterial lipopolysaccharide.
  • To determine if vascular smooth muscle cells are a source of TNF production.

Main Methods:

  • Segments of human internal mammary artery and saphenous vein were obtained from patients undergoing coronary artery bypass surgery.
  • Vascular tissue segments and cultured smooth muscle cells were incubated with or without bacterial lipopolysaccharide.
  • Time-course analysis of TNF release into the medium was performed using enzyme assays.

Main Results:

  • Bacterial lipopolysaccharide significantly stimulated TNF release from both saphenous vein and internal mammary artery segments in a time-dependent manner.
  • TNF levels were markedly higher in lipopolysaccharide-treated vascular tissue compared to controls at various time points.
  • Cultured smooth muscle cells from both artery and vein also released significant amounts of TNF upon stimulation with bacterial lipopolysaccharide.

Conclusions:

  • Human arteries and veins possess the capacity to produce TNF.
  • Vascular smooth muscle cells are a likely source of TNF production in response to bacterial lipopolysaccharide.
  • These findings suggest that vascular tissue may play a direct role in the inflammatory processes of septic shock.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.